Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC)

ABSTRACT: A phase II trial was launched to evaluate if neoadjuvant stereotactic ablative radiotherapy (SABR) before surgery improves oncologic outcomes in patients with stage I non-small cell lung cancer (NSCLC). We report a mandated interim safety analysis for the first 10 patients who completed pr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Radiat Oncol
Päätekijät: Palma, David A., Nguyen, Timothy K., Kwan, Keith, Gaede, Stewart, Landis, Mark, Malthaner, Richard, Fortin, Dalilah, Louie, Alexander V., Frechette, Eric, Rodrigues, George B., Yaremko, Brian, Yu, Edward, Dar, A. Rashid, Lee, Ting-Yim, Gratton, Al, Warner, Andrew, Ward, Aaron, Inculet, Richard
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Short Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5270342/
https://ncbi.nlm.nih.gov/pubmed/28129789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0770-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia